Related Experiment Videos
Leukemia following radiotherapy for uterine bleeding
P D Inskip1, R R Monson, J K Wagoner
1Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115.
Radiation Research
|May 1, 1990
Summary
Radiation therapy for uterine bleeding significantly increased leukemia risk in women, with higher risks observed shortly after treatment and in older individuals. This study highlights the long-term health impacts of radiation exposure.
Area of Science:
- Medical Physics
- Epidemiology
- Oncology
Background:
- Historically, radiation therapy was used to treat benign gynecologic conditions like uterine bleeding.
- Long-term health effects, including cancer risk, require ongoing investigation for previously employed medical treatments.
Purpose of the Study:
- To assess the leukemia mortality risk in women treated with radiation for uterine bleeding.
- To quantify the dose-response relationship between radiation exposure and leukemia development.
Main Methods:
- A cohort study of 4483 women treated between 1925-1965.
- Follow-up for an average of 26.4 years, with mortality data compared to U.S. population rates.
- Estimation of average bone marrow radiation dose from radiotherapy records.
Main Results:
- Leukemia mortality was double the expected rate (SMR=2.0).
- Relative risk peaked 2-5 years post-treatment (SMR=8.1) and in women over 55 (SMR=5.8).
- A linear dose-response was observed, with excess relative risk of 1.9% per cGy.
Conclusions:
- Radiation doses for benign gynecologic conditions may pose a higher leukemia risk per cGy than those for malignant diseases.
- Findings underscore the importance of careful radiation dose management even for non-cancerous conditions.